(Q40700770)

22 September 2017

Use of Rituximab in Systemic Lupus Erythematosus: A Single Center Experience Over 14 Years (English)

1 reference

systemic lupus erythematosus

22 September 2017

1 reference

1 reference

4

D Isenberg

1 reference

22 September 2017

R Aguiar

1

1 reference

PubMed ID

27110698

22 September 2017

C Araújo

series ordinal

2

1 reference

PubMed ID

27110698

22 September 2017

G Martins-Coelho

series ordinal

3

1 reference

22 September 2017

25 April 2016

1 reference

Arthritis Care and Research

22 September 2017

1 reference

22 September 2017

69

1 reference

22 September 2017

2

1 reference

22 September 2017

257-262

1 reference

EULAR recommendations for the management of systemic lupus erythematosus. Report of a Task Force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics

22 September 2017

1 reference

Treat-to-target in systemic lupus erythematosus: recommendations from an international task force.

21 January 2018

1 reference

B cells as therapeutic targets in SLE.

21 January 2018

1 reference

Efficacy and safety of rituximab in moderately-to-severely active systemic lupus erythematosus: the randomized, double-blind, phase II/III systemic lupus erythematosus evaluation of rituximab trial

21 January 2018

1 reference

Efficacy and safety of rituximab in patients with active proliferative lupus nephritis: the Lupus Nephritis Assessment with Rituximab study

21 January 2018

1 reference

Rituximab in systemic lupus erythematosus: A systematic review of off-label use in 188 cases

21 January 2018

1 reference

A retrospective seven-year analysis of the use of B cell depletion therapy in systemic lupus erythematosus at University College London Hospital: the first fifty patients

21 January 2018

1 reference

Safety and efficacy of rituximab in systemic lupus erythematosus: results from 136 patients from the French AutoImmunity and Rituximab registry

21 January 2018

1 reference

Clinical outcomes and safety of rituximab treatment for patients with systemic lupus erythematosus (SLE) - results from a nationwide cohort in Germany (GRAID).

21 January 2018

1 reference

Rituximab is an effective treatment for lupus nephritis and allows a reduction in maintenance steroids.

21 January 2018

1 reference

Prospective observational single-centre cohort study to evaluate the effectiveness of treating lupus nephritis with rituximab and mycophenolate mofetil but no oral steroids.

21 January 2018

1 reference

Early treatment with rituximab in newly diagnosed systemic lupus erythematosus patients: a steroid-sparing regimen.

21 January 2018

1 reference

Longer duration of B cell depletion is associated with better outcome

21 January 2018

1 reference

Sustained improvement in rheumatoid arthritis following a protocol designed to deplete B lymphocytes

21 January 2018

1 reference

Efficacy of B-cell-targeted therapy with rituximab in patients with rheumatoid arthritis

21 January 2018

1 reference

Efficacy of rituximab in 164 patients with biopsy-proven lupus nephritis: pooled data from European cohorts

21 January 2018

1 reference

Long-term follow-up in lupus nephritis patients treated with rituximab--clinical and histopathological response

21 January 2018

1 reference

Efficacy and safety of rituximab in Japanese patients with systemic lupus erythematosus and lupus nephritis who are refractory to conventional therapy

21 January 2018

1 reference

A 4-year observation in lupus nephritis patients treated with an intensified B-lymphocyte depletion without immunosuppressive maintenance treatment-Clinical response compared to literature and immunological re-assessment

21 January 2018

1 reference

American College of Rheumatology guidelines for screening, treatment, and management of lupus nephritis

21 January 2018

1 reference

Joint European League Against Rheumatism and European Renal Association-European Dialysis and Transplant Association (EULAR/ERA-EDTA) recommendations for the management of adult and paediatric lupus nephritis

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/ACR.22921

1 reference

22 September 2017

1 reference

PubMed ID

27110698